NBIX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $41,542,271.53

Neurocrine Biosciences Insider Trading History Chart

Neurocrine Biosciences Share Price & Price History

^$138.98

▲ +1.35 (0.98%)

As of 02/3/2026 05:00 PM ET

Days: 30 | 90 | 365

Neurocrine Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/16/2026	Kyle Gano	CEO	Sell	36,400	$132.70	$4,830,280.00	140,407
12/16/2025	Leslie V Norwalk	Director	Sell	1,190	$155.09	$184,557.10	6,239
12/15/2025	Leslie V Norwalk	Director	Sell	5,000	$152.23	$761,150.00	7,429
12/8/2025	Darin Lippoldt	Insider	Sell	4,376	$159.65	$698,628.40	43,405
11/25/2025	George J Morrow	Director	Sell	15,000	$143.37	$2,150,550.00	7,068
11/5/2025	William H. Rastetter	Director	Sell	18,000	$151.82	$2,732,760.00	40,360
11/4/2025	Kyle Gano	CEO	Sell	300	$141.97	$42,591.00	140,407
8/7/2025	Kevin Charles Gorman	Director	Sell	106,322	$126.41	$13,440,164.02	514,596
7/10/2025	Ingrid Delaet	Insider	Sell	457	$135.00	$61,695.00	4,730
7/9/2025	Jude Onyia	Insider	Sell	59,819	$130.46	$7,803,986.74	18,289
7/2/2025	Jude Onyia	Insider	Sell	20,362	$130.13	$2,649,707.06	18,289
5/27/2025	Kevin Charles Gorman	Director	Sell	9,613	$120.38	$1,157,212.94	514,596
5/5/2025	William H. Rastetter	Director	Sell	30,000	$110.20	$3,306,000.00	37,491
2/13/2025	Julie Cooke	Insider	Sell	1,551	$116.78	$181,125.78	19,544
2/13/2025	Kevin Charles Gorman	Director	Sell	5,844	$116.69	$681,936.36	521,618
2/13/2025	Matt Abernethy	CFO	Sell	2,558	$116.86	$298,927.88	34,775
2/10/2025	Julie Cooke	Insider	Sell	700	$118.28	$82,796.00	18,831
2/10/2025	Kevin Charles Gorman	Director	Sell	2,274	$118.37	$269,173.38	519,074
2/10/2025	Kyle Gano	CEO	Sell	980	$118.39	$116,022.20	137,658
2/3/2025	Ingrid Delaet	Insider	Sell	623	$149.29	$93,007.67	3,442
1/31/2025	Julie Cooke	Insider	Sell	1,740	$152.89	$266,028.60	18,202
1/31/2025	Kevin Charles Gorman	Director	Sell	2,707	$152.92	$413,954.44	517,030
1/31/2025	Kyle Gano	CEO	Sell	1,541	$152.87	$235,572.67	136,778
1/31/2025	Matt Abernethy	CFO	Sell	1,283	$152.87	$196,132.21	32,681
1/27/2025	Kevin Charles Gorman	Director	Sell	146,105	$149.46	$21,836,853.30	514,596
1/15/2025	Kyle Gano	CEO	Sell	65,000	$141.50	$9,197,500.00	135,392
12/31/2024	Ingrid Delaet	Insider	Sell	272	$138.10	$37,563.20	2,507
12/17/2024	Ingrid Delaet	Insider	Sell	1,091	$135.00	$147,285.00	2,507
11/29/2024	Jude Onyia	Insider	Sell	2,331	$126.29	$294,381.99	15,449
8/15/2024	William H. Rastetter	Director	Sell	14,250	$146.69	$2,090,332.50	37,491
8/13/2024	Gary A. Lyons	Director	Sell	11,570	$150.43	$1,740,475.10	119,047
8/13/2024	Ingrid Delaet	Insider	Sell	7,143	$150.10	$1,072,164.30	2,507
8/13/2024	Matt Abernethy	CFO	Sell	14,100	$150.38	$2,120,358.00	31,528
8/6/2024	Ingrid Delaet	Insider	Sell	273	$147.70	$40,322.10	6,607
8/1/2024	Julie Cooke	Insider	Sell	12,632	$153.26	$1,935,980.32	18,202
7/16/2024	Gary A. Lyons	Director	Sell	930	$150.03	$139,527.90	119,047
7/16/2024	Julie Cooke	Insider	Sell	900	$150.04	$135,036.00	18,202
7/1/2024	Julie Cooke	Insider	Sell	10,000	$140.19	$1,401,900.00	18,202
5/29/2024	Stephen A. Sherwin	Director	Sell	40,000	$133.46	$5,338,400.00	26,504
5/17/2024	Shalini Sharp	Director	Sell	1,106	$141.90	$156,941.40	994
5/15/2024	Matt Abernethy	CFO	Sell	15,000	$140.24	$2,103,600.00	31,528
5/14/2024	Gary A. Lyons	Director	Sell	12,500	$135.63	$1,695,375.00	116,947
5/6/2024	Ingrid Delaet	Insider	Sell	273	$140.55	$38,370.15	7,507
4/15/2024	Eric Benevich	Insider	Sell	19,818	$133.36	$2,642,928.48	40,778
3/21/2024	Ingrid Delaet	Insider	Sell	5,000	$145.06	$725,300.00	7,507
3/14/2024	Eric Benevich	Insider	Sell	75,000	$139.38	$10,453,500.00	40,778
3/14/2024	George J. Morrow	Director	Sell	40,000	$139.42	$5,576,800.00
3/11/2024	Ingrid Delaet	Insider	Sell	200	$140.00	$28,000.00	7,507
3/11/2024	Richard F. Pops	Director	Sell	100	$140.00	$14,000.00	29,512
3/8/2024	Ingrid Delaet	Insider	Sell	1,800	$140.03	$252,054.00	7,507
3/8/2024	Richard F. Pops	Director	Sell	1,700	$140.05	$238,085.00	29,512
2/29/2024	Ingrid Delaet	Insider	Sell	273	$135.51	$36,994.23	7,507
2/27/2024	Leslie V. Norwalk	Director	Sell	8,000	$135.67	$1,085,360.00
2/20/2024	Richard F. Pops	Director	Sell	15,000	$132.47	$1,987,050.00	29,512
2/13/2024	Eiry Roberts	Insider	Sell	1,114	$132.96	$148,117.44	23,716
2/13/2024	Kevin Charles Gorman	CEO	Sell	2,832	$133.02	$376,712.64	514,596
2/13/2024	Matt Abernethy	CFO	Sell	1,352	$132.85	$179,613.20	31,528
2/8/2024	David W. Boyer	Insider	Sell	1,328	$135.41	$179,824.48	4,895
2/8/2024	Kevin Charles Gorman	CEO	Sell	2,274	$134.15	$305,057.10	506,962
2/8/2024	Matt Abernethy	CFO	Sell	980	$134.21	$131,525.80	30,314
2/6/2024	David W. Boyer	Insider	Sell	456	$141.96	$64,733.76	4,894
2/6/2024	Kevin Charles Gorman	CEO	Sell	3,040	$142.18	$432,227.20	504,919
2/6/2024	Matt Abernethy	CFO	Sell	1,280	$142.19	$182,003.20	29,434
1/31/2024	Eiry Roberts	Insider	Sell	1,457	$140.79	$205,131.03	20,832
1/31/2024	Kevin Charles Gorman	CEO	Sell	2,707	$140.69	$380,847.83	502,188
1/31/2024	Matt Abernethy	CFO	Sell	1,283	$140.72	$180,543.76	28,284
1/22/2024	Darin Lippoldt	Insider	Sell	10,000	$139.86	$1,398,600.00	35,882
1/8/2024	Kevin Charles Gorman	CEO	Sell	105,835	$132.44	$14,016,787.40	499,754
1/2/2024	Kyle Gano	Insider	Sell	75,000	$131.47	$9,860,250.00	130,250
1/2/2024	William H. Rastetter	Director	Sell	11,044	$131.47	$1,451,954.68	51,741
12/22/2023	Eiry Roberts	Insider	Sell	10,000	$126.74	$1,267,400.00	19,521
12/12/2023	Eiry Roberts	Insider	Sell	13,925	$120.30	$1,675,177.50	29,521
12/8/2023	Eiry Roberts	Insider	Sell	300	$120.10	$36,030.00	29,521
12/6/2023	Darin Lippoldt	Insider	Sell	20,830	$119.86	$2,496,683.80	35,882
12/1/2023	Gary A. Lyons	Director	Sell	5,000	$116.77	$583,850.00	203,697
11/29/2023	Jude Onyia	Insider	Sell	2,331	$113.57	$264,731.67	11,732
11/27/2023	Darin Lippoldt	Insider	Sell	10,919	$112.27	$1,225,876.13	35,882
10/2/2023	David W. Boyer	Insider	Sell	1,437	$112.68	$161,921.16	4,894
9/12/2023	Gary A. Lyons	Director	Sell	5,000	$115.02	$575,100.00	203,697
9/1/2023	Gary A. Lyons	Director	Sell	5,000	$110.06	$550,300.00	203,697
9/1/2023	Julie Cooke	Insider	Sell	824	$110.93	$91,406.32	17,263
8/30/2023	David W. Boyer	Insider	Sell	2,733	$107.60	$294,070.80	3,460
8/28/2023	Ingrid Delaet	Insider	Sell	1,431	$107.52	$153,861.12	5,931
8/21/2023	Jude Onyia	Insider	Sell	3,198	$107.37	$343,369.26	9,638
8/21/2023	Kevin Charles Gorman	CEO	Sell	9,328	$107.40	$1,001,827.20	499,754
8/21/2023	Matt Abernethy	CFO	Sell	2,132	$107.39	$228,955.48	27,131
5/1/2023	Julie Cooke	Insider	Sell	11,397	$103.89	$1,184,034.33	16,169
5/1/2023	William H. Rastetter	Director	Sell	4,300	$101.43	$436,149.00	42,785
4/24/2023	Eiry Roberts	Insider	Sell	14,400	$103.48	$1,490,112.00	26,644
4/21/2023	William H. Rastetter	Director	Sell	6,034	$105.04	$633,811.36	39,460
4/19/2023	William H. Rastetter	Director	Sell	903	$105.00	$94,815.00	34,729
2/23/2023	Neurocrine Biosciences Inc	Major Shareholder	Buy	4,395,588	$8.88	$39,032,821.44	8,575,316
2/8/2023	Eric Benevich	Insider	Sell	980	$104.12	$102,037.60	34,381
2/8/2023	Kevin Charles Gorman	CEO	Sell	2,274	$104.30	$237,178.20	491,365
2/7/2023	Matt Abernethy	CFO	Sell	26,328	$102.40	$2,695,987.20	24,333
2/6/2023	Eric Benevich	Insider	Sell	1,280	$105.63	$135,206.40	17,879
2/6/2023	Kevin Charles Gorman	CEO	Sell	3,040	$105.68	$321,267.20	468,008

SEC Filings (Institutional Ownership Changes) for Neurocrine Biosciences (NASDAQ:NBIX)

92.59% of Neurocrine Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Neurocrine Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/3/2026	Crossmark Global Holdings Inc.	8,367	$1.19M	0.0%	+6.5%	0.008%
2/3/2026	Wesbanco Bank Inc.	17,000	$2.41M	0.1%	+88.9%	0.017%
2/3/2026	Generali Asset Management SPA SGR	22,703	$3.22M	0.1%	-13.9%	0.023%
2/3/2026	MGO One Seven LLC	3,603	$0.51M	0.0%	N/A	0.004%
2/3/2026	Allegiance Financial Group Advisory Services LLC	2,272	$0.32M	0.1%	+27.4%	0.002%
2/3/2026	Sequoia Financial Advisors LLC	5,743	$0.82M	0.0%	+30.9%	0.006%
2/3/2026	Swedbank AB	584,129	$82.85M	0.1%	+6.7%	0.586%
2/3/2026	Mitsubishi UFJ Asset Management Co. Ltd.	100,222	$14.09M	0.0%	+10.6%	0.101%
2/3/2026	BOKF NA	2,166	$0.31M	0.0%	-16.7%	0.002%
2/3/2026	Sumitomo Mitsui DS Asset Management Company Ltd	10,171	$1.44M	0.0%	-1.3%	0.010%
2/2/2026	QRG Capital Management Inc.	16,214	$2.30M	0.0%	-16.6%	0.016%
2/2/2026	Pinnacle Wealth Management Advisory Group LLC	2,006	$0.29M	0.0%	N/A	0.002%
2/2/2026	Truist Financial Corp	10,991	$1.56M	0.0%	-68.9%	0.011%
2/2/2026	Advisors Preferred LLC	29,867	$4.20M	0.7%	N/A	0.030%
2/2/2026	Seizert Capital Partners LLC	70,670	$10.02M	0.4%	+0.9%	0.071%
2/2/2026	PKO Investment Management Joint Stock Co	1,300	$0.18M	0.0%	N/A	0.001%
2/2/2026	Horizon Investments LLC	55,090	$7.81M	0.1%	+42.7%	0.055%
2/2/2026	Danske Bank A S	47,216	$6.70M	0.0%	+8.8%	0.047%
2/2/2026	GenTrust LLC	1,760	$0.25M	0.0%	N/A	0.002%
2/2/2026	Oppenheimer & Co. Inc.	40,591	$5.76M	0.1%	-1.1%	0.041%
2/2/2026	Oppenheimer Asset Management Inc.	14,412	$2.04M	0.0%	-6.3%	0.014%
1/30/2026	New York State Teachers Retirement System	95,631	$13.56M	0.0%	-3.1%	0.096%
1/30/2026	State of New Jersey Common Pension Fund D	33,930	$4.81M	0.0%	-2.7%	0.034%
1/30/2026	Keybank National Association OH	2,833	$0.40M	0.0%	-3.9%	0.003%
1/30/2026	AMG National Trust Bank	12,326	$1.75M	0.0%	N/A	0.012%
1/30/2026	Mitsubishi UFJ Trust & Banking Corp	79,895	$11.33M	0.0%	+1.1%	0.080%
1/30/2026	M&T Bank Corp	4,318	$0.61M	0.0%	+30.4%	0.004%
1/29/2026	Comerica Bank	27,450	$3.89M	0.0%	-7.2%	0.028%
1/29/2026	Ashton Thomas Private Wealth LLC	1,541	$0.22M	0.0%	N/A	0.002%
1/29/2026	Washington Capital Management Inc.	4,400	$0.62M	0.5%	-15.4%	0.004%
1/29/2026	Gray Foundation	37,800	$5.36M	1.3%	N/A	0.038%
1/29/2026	Pictet Asset Management Holding SA	776,934	$110.31M	0.1%	+12.0%	0.779%
1/29/2026	UBS Group AG	983,528	$139.49M	0.0%	+169.8%	0.986%
1/29/2026	Sanctuary Advisors LLC	8,450	$1.20M	0.0%	+4.8%	0.008%
1/29/2026	Vanguard Group Inc.	9,700,301	$1.38B	0.0%	-0.1%	9.729%
1/29/2026	Munich Reinsurance Co Stock Corp in Munich	24,821	$3.50M	0.1%	+69.4%	0.025%
1/29/2026	Generali Investments Management Co LLC	8,907	$1.26M	0.3%	+79.6%	0.009%
1/29/2026	China Universal Asset Management Co. Ltd.	16,247	$2.30M	0.2%	-6.5%	0.016%
1/29/2026	Riggs Asset Managment Co. Inc.	3,818	$0.54M	0.1%	N/A	0.004%
1/28/2026	Arizona State Retirement System	27,226	$3.86M	0.0%	-6.8%	0.027%
1/28/2026	Chicago Partners Investment Group LLC	5,359	$0.73M	0.0%	+50.3%	0.005%
1/28/2026	Peregrine Capital Management LLC	57,578	$8.17M	0.3%	-2.2%	0.058%
1/28/2026	waypoint wealth counsel	3,300	$0.47M	0.2%	+8.5%	0.003%
1/28/2026	B. Metzler seel. Sohn & Co. AG	4,737	$0.67M	0.0%	-11.6%	0.005%
1/28/2026	Teacher Retirement System of Texas	16,070	$2.28M	0.0%	-37.1%	0.016%
1/28/2026	HB Wealth Management LLC	4,819	$0.68M	0.0%	+35.0%	0.005%
1/28/2026	Ruffer LLP	17,453	$2.48M	0.1%	N/A	0.018%
1/28/2026	M&T Bank Corp	8,980	$1.27M	0.0%	+171.2%	0.009%
1/28/2026	Universal Beteiligungs und Servicegesellschaft mbH	65,027	$9.22M	0.0%	+12.4%	0.065%
1/27/2026	Evergreen Capital Management LLC	2,364	$0.34M	0.0%	-7.9%	0.002%
1/27/2026	Zurcher Kantonalbank Zurich Cantonalbank	97,450	$13.82M	0.0%	+44.7%	0.098%
1/27/2026	Belpointe Asset Management LLC	9,485	$1.35M	0.0%	N/A	0.010%
1/27/2026	Fortis Capital Advisors LLC	9,485	$1.35M	0.2%	N/A	0.010%
1/27/2026	Krilogy Financial LLC	11,446	$1.54M	0.1%	+38.1%	0.011%
1/27/2026	Earned Wealth Advisors LLC	2,636	$0.37M	0.0%	+6.9%	0.003%
1/27/2026	Bayforest Capital Ltd	1,963	$0.28M	0.2%	-10.0%	0.002%
1/27/2026	Seeds Investor LLC	2,494	$0.35M	0.1%	+10.3%	0.003%
1/27/2026	Tokio Marine Asset Management Co. Ltd.	4,968	$0.71M	0.0%	+3.6%	0.005%
1/27/2026	Friedenthal Financial	7,276	$1.03M	0.5%	N/A	0.007%
1/27/2026	Asset Management One Co. Ltd.	44,208	$6.35M	0.0%	+8.2%	0.044%
1/27/2026	GF Fund Management CO. LTD.	1,958	$0.28M	0.0%	-8.2%	0.002%
1/27/2026	Juncture Wealth Strategies LLC	4,796	$0.68M	0.2%	+2.7%	0.005%
1/26/2026	Merit Financial Group LLC	17,531	$2.49M	0.0%	+19.9%	0.018%
1/26/2026	Mirae Asset Global Investments Co. Ltd.	16,716	$2.37M	0.0%	+13.6%	0.017%
1/26/2026	Parcion Private Wealth LLC	3,776	$0.54M	0.0%	+55.3%	0.004%
1/26/2026	Nations Financial Group Inc. IA ADV	2,528	$0.36M	0.0%	N/A	0.003%
1/26/2026	CWM LLC	95,030	$13.48M	0.0%	+13.5%	0.095%
1/26/2026	KBC Group NV	32,401	$4.60M	0.0%	+122.4%	0.032%
1/26/2026	LBP AM SA	1,580	$0.22M	0.0%	-31.8%	0.002%
1/26/2026	MOKAN Wealth Management Inc.	1,943	$0.28M	0.1%	+24.2%	0.002%
1/23/2026	Farther Finance Advisors LLC	2,754	$0.39M	0.0%	+142.9%	0.003%
1/23/2026	Assetmark Inc.	19,321	$2.74M	0.0%	-4.5%	0.019%
1/23/2026	Transcend Capital Advisors LLC	2,519	$0.36M	0.0%	+13.5%	0.003%
1/23/2026	State of Alaska Department of Revenue	9,965	$1.41M	0.0%	-6.1%	0.010%
1/23/2026	Stanley Laman Group Ltd.	27,618	$3.92M	0.5%	+8.9%	0.028%
1/23/2026	Burney Co.	8,690	$1.23M	0.0%	-69.9%	0.009%
1/23/2026	Choreo LLC	3,670	$0.52M	0.0%	-8.2%	0.004%
1/23/2026	Sumitomo Mitsui Trust Group Inc.	202,666	$28.74M	0.0%	-8.4%	0.203%
1/23/2026	Altfest L J & Co. Inc.	2,835	$0.40M	0.0%	+8.0%	0.003%
1/23/2026	Robeco Institutional Asset Management B.V.	113,261	$16.06M	0.0%	+301.8%	0.114%
1/23/2026	Ritholtz Wealth Management	1,521	$0.22M	0.0%	N/A	0.002%
1/22/2026	Massachusetts Financial Services Co. MA	126,341	$17.92M	0.0%	-7.6%	0.127%
1/22/2026	Jackson Thornton Wealth Management LLC	3,508	$0.48M	0.0%	+4.1%	0.004%
1/22/2026	V Square Quantitative Management LLC	1,676	$0.24M	0.0%	N/A	0.002%
1/21/2026	Yousif Capital Management LLC	32,046	$4.31M	0.0%	-1.5%	0.032%
1/21/2026	Greenleaf Trust	1,475	$0.21M	0.0%	N/A	0.001%
1/21/2026	Robinhood Asset Management LLC	40,296	$5.72M	0.5%	N/A	0.040%
1/20/2026	BAM Wealth Management LLC	2,343	$0.33M	0.2%	+13.1%	0.002%
1/20/2026	Braun Stacey Associates Inc.	182,262	$25.85M	0.8%	-0.4%	0.183%
1/20/2026	Signaturefd LLC	1,925	$0.27M	0.0%	+4.5%	0.002%
1/20/2026	Savvy Advisors Inc.	2,374	$0.34M	0.0%	+37.7%	0.002%
1/20/2026	Whalen Wealth Management Inc.	5,125	$0.73M	0.4%	+14.9%	0.005%
1/20/2026	Perpetual Ltd	2,739	$0.39M	0.0%	N/A	0.003%
1/16/2026	Perigon Wealth Management LLC	2,590	$0.37M	0.0%	+3.1%	0.003%
1/16/2026	Aberdeen Group plc	40,016	$5.68M	0.0%	-55.6%	0.040%
1/16/2026	Earned Wealth Advisors LLC	2,636	$0.37M	0.0%	+6.9%	0.003%
1/16/2026	Tema Etfs LLC	3,548	$0.50M	0.0%	-3.0%	0.004%
1/15/2026	Nilsine Partners LLC	8,437	$1.20M	0.1%	N/A	0.008%
1/15/2026	Nisa Investment Advisors LLC	5,201	$0.74M	0.0%	-80.8%	0.005%
1/15/2026	Allspring Global Investments Holdings LLC	339,432	$47.72M	0.1%	-11.2%	0.340%

Data available starting January 2016

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids. Its product candidates in clinical development include valbenazine to treat dyskinetic cerebral palsy in pediatrics and adults; NBI-921352 to treat developmental and epileptic encephalopathy syndrome in pediatrics and adults; NBI-827104 to treat epileptic encephalopathy with continuous spike-and-wave during sleep; NBI-1076986 to treat movement disorders; crinecerfront to treat congenital adrenal hyperplasia in adults and children; EFMODY to treat congenital adrenal hyperplasia and adrenal insufficiency in adults; valbenazine for the adjunctive treatment of schizophrenia; NBI-1065845 for the treatment of inadequate response to treatment in major depressive disorder; luvadaxistat to treat cognitive impairment related to schizophrenia; NBI-1117568 for the treatment of schizophrenia; NBI-1070770 to treat major depressive disorder; NBI-1117570 for the treatment of symptoms of psychosis and cognition in neurological and neuropsychiatric conditions; and NBI-1117569, NBI-1117567, and NBI-1065890 to treat CNS indications. The company also has license and collaboration agreements with Heptares Therapeutics Limited; Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Today's Range

Now: $138.98

$137.04

$141.24

50 Day Range

MA: $142.97

$132.26

$155.63

52 Week Range

Now: $138.98

$84.23

$160.18

Volume

996,849 shs

Average Volume

1,038,221 shs

Market Capitalization

$13.86 billion

P/E Ratio

33.25

Dividend Yield

N/A

Beta

0.31

Who are the company insiders with the largest holdings of Neurocrine Biosciences?: Neurocrine Biosciences' top insider shareholders include:
Kevin Charles Gorman (Director)
Kevin Charles Gorman (CEO)
Kyle Gano (CEO)
Gary A Lyons (Director)
Darin Lippoldt (Insider)
Eric Benevich (Insider)
William H Rastetter (Director)
Matt Abernethy (CFO)
Richard F Pops (Director)
Stephen A Sherwin (Director)
Eiry Roberts (Insider)
Julie Cooke (Insider)
Jude Onyia (Insider)
Ingrid Delaet (Insider)
Leslie V Norwalk (Director)
George J Morrow (Director)
David W Boyer (Insider)
Shalini Sharp (Director)
George J Morrow (Director)
Leslie V Norwalk (Director)
Learn More about top insider investors at Neurocrine Biosciences.
Who are the major institutional investors of Neurocrine Biosciences?: Neurocrine Biosciences' top institutional investors include:
Vanguard Group Inc. — 9.73%
UBS Group AG — 0.99%
Pictet Asset Management Holding SA — 0.78%
Allspring Global Investments Holdings LLC — 0.34%
Sumitomo Mitsui Trust Group Inc. — 0.20%
Braun Stacey Associates Inc. — 0.18%
Learn More about top institutional investors of Neurocrine Biosciences stock.
Which institutional investors are selling Neurocrine Biosciences stock?: During the previous quarter, NBIX stock was sold by these institutional investors:
Aberdeen Group plc
Allspring Global Investments Holdings LLC
Truist Financial Corp
Nisa Investment Advisors LLC
Burney Co.
Sumitomo Mitsui Trust Group Inc.
Massachusetts Financial Services Co. MA
Teacher Retirement System of Texas
During the previous year, company insiders that have sold Neurocrine Biosciences company stock include:
Kevin Charles Gorman (Director)
Kevin Charles Gorman (CEO)
Kyle Gano (CEO)
Gary A Lyons (Director)
Darin Lippoldt (Insider)
Eric Benevich (Insider)
William H Rastetter (Director)
Matt Abernethy (CFO)
Richard F Pops (Director)
Stephen A Sherwin (Director)
Learn More investors selling Neurocrine Biosciences stock.
Which institutional investors are buying Neurocrine Biosciences stock?: Within the previous quarter, NBIX stock was bought by institutional investors including:
UBS Group AG
SG Americas Securities LLC
Robeco Institutional Asset Management B.V.
Pictet Asset Management Holding SA
Robinhood Asset Management LLC
Gray Foundation
Assenagon Asset Management S.A.
Zurcher Kantonalbank Zurich Cantonalbank